Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Dianne Hartgerink"'
Autor:
Dianne Hartgerink, Britt van der Heijden, Dirk De Ruysscher, Alida Postma, Linda Ackermans, Ann Hoeben, Monique Anten, Philippe Lambin, Karin Terhaag, Arthur Jochems, Andre Dekker, Janna Schoenmaekers, Lizza Hendriks, Jaap Zindler
Publikováno v:
Frontiers in Oncology, Vol 8 (2018)
Brain metastases (BM) frequently occur in non-small cell lung cancer (NSCLC) patients. Most patients with BM have a limited life expectancy, measured in months. Selected patients may experience a very long progression-free survival, for example, pati
Externí odkaz:
https://doaj.org/article/6174674384ed4b5190ce57bc761e30d0
Autor:
A. Bruynzeel, E. Dieleman, Peter-Paul van der Toorn, Annemarie T. Swaak-Kragten, A. Swinnen, Jaap D. Zindler, Ruud Wiggenraad, Daniëlle B.P. Eekers, Frank J. Lagerwaard, Dirk De Ruysscher, Joost J.C. Verhoeff, Lieneke van Veelen, Coen W. Hurkmans, Philippe Lambin, Dianne Hartgerink
Publikováno v:
Annals of Palliative Medicine, 11(4), 1197-1209. AME Publishing Company
Annals of palliative medicine, 11(4), 1197-1209. AME Publishing Company
Hartgerink, D, Bruynzeel, A, Eekers, D, Swinnen, A, Hurkmans, C, Wiggenraad, R, Swaak-Kragten, A, Dieleman, E, van der Toorn, P-P, van Veelen, L, Verhoeff, J J C, Lagerwaard, F, de Ruysscher, D, Lambin, P & Zindler, J 2022, ' Quality of life among patients with 4 to 10 brain metastases after treatment with whole-brain radiotherapy vs. stereotactic radiotherapy : a phase III, randomized, Dutch multicenter trial ', Annals of Palliative Medicine, vol. 11, no. 4, pp. 1197-1209 . https://doi.org/10.21037/apm-21-1545
Annals of palliative medicine, 11(4), 1197-1209. AME Publishing Company
Hartgerink, D, Bruynzeel, A, Eekers, D, Swinnen, A, Hurkmans, C, Wiggenraad, R, Swaak-Kragten, A, Dieleman, E, van der Toorn, P-P, van Veelen, L, Verhoeff, J J C, Lagerwaard, F, de Ruysscher, D, Lambin, P & Zindler, J 2022, ' Quality of life among patients with 4 to 10 brain metastases after treatment with whole-brain radiotherapy vs. stereotactic radiotherapy : a phase III, randomized, Dutch multicenter trial ', Annals of Palliative Medicine, vol. 11, no. 4, pp. 1197-1209 . https://doi.org/10.21037/apm-21-1545
Background: Stereotactic radiotherapy (SRT) is an attractive treatment option for patients with brain metastases (BM), sparing healthy brain tissue and likely controlling local tumors. Most previous studies have focused on radiological response or su
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ac96fc1d4ea76e0360374ec55b474ee0
https://research.vumc.nl/en/publications/f6de6eaa-a6e6-40e7-8aad-ce5fcbb342db
https://research.vumc.nl/en/publications/f6de6eaa-a6e6-40e7-8aad-ce5fcbb342db
Autor:
Dirk De Ruysscher, Frank J. Lagerwaard, Joost J.C. Verhoeff, E. Dieleman, Dianne Hartgerink, Coen W. Hurkmans, Philippe Lambin, Peter-Paul van der Toorn, Ruud Wiggenraad, Bing Oei, A. Bruynzeel, Annemarie T. Swaak-Kragten, J. Zindler, A. Swinnen, Daniëlle B.P. Eekers, Lieneke van Veelen
Publikováno v:
Neuro-oncology advances, 3(1):vdab021. Oxford University Press
Neuro-oncology Advances
Neuro-Oncology Advances, 3(1):vdab021. Oxford University Press
Hartgerink, D, Bruynzeel, A, Eekers, D, Swinnen, A, Hurkmans, C, Wiggenraad, R, Swaak-Kragten, A, Dieleman, E, van der Toorn, P-P, Oei, B, van Veelen, L, Verhoeff, J, Lagerwaard, F, de Ruysscher, D, Lambin, P & Zindler, J 2021, ' A Dutch phase III randomized multicenter trial : Whole brain radiotherapy versus stereotactic radiotherapy for 4-10 brain metastases ', Neuro-oncology advances, vol. 3, no. 1, vdab021 . https://doi.org/10.1093/noajnl/vdab021
Neuro-oncology Advances
Neuro-Oncology Advances, 3(1):vdab021. Oxford University Press
Hartgerink, D, Bruynzeel, A, Eekers, D, Swinnen, A, Hurkmans, C, Wiggenraad, R, Swaak-Kragten, A, Dieleman, E, van der Toorn, P-P, Oei, B, van Veelen, L, Verhoeff, J, Lagerwaard, F, de Ruysscher, D, Lambin, P & Zindler, J 2021, ' A Dutch phase III randomized multicenter trial : Whole brain radiotherapy versus stereotactic radiotherapy for 4-10 brain metastases ', Neuro-oncology advances, vol. 3, no. 1, vdab021 . https://doi.org/10.1093/noajnl/vdab021
Background The clinical value of whole brain radiotherapy (WBRT) for brain metastases (BM) is a matter of debate due to the significant side effects involved. Stereotactic radiosurgery (SRS) is an attractive alternative treatment option that may avoi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5b54715f54c43def81baf7058e2a2e23
https://research.vumc.nl/en/publications/85156bb5-970b-4007-bd4b-110b6cb11ac2
https://research.vumc.nl/en/publications/85156bb5-970b-4007-bd4b-110b6cb11ac2
Autor:
P. Lambin, Annemarie T. Swaak-Kragten, Frank J. Lagerwaard, P.P. van der Toorn, A. Swinnen, Joost J.C. Verhoeff, L. van Veelen, Daniëlle B.P. Eekers, A. Bruynzeel, Dianne Hartgerink, E. Dieleman, Ruud Wiggenraad, Dirk De Ruysscher, Jaap D. Zindler, Bing Oei, Coen W. Hurkmans
Publikováno v:
SSRN Electronic Journal.
Background: Since publication of the QUARTZ trial, the clinical value of whole brain radiotherapy (WBRT) for brain metastases is a matter of debate due to significant side effects. In order to avoid these side effects and to improve local tumor contr
Autor:
R. Wiggenraad, P. Lambin, Dirk De Ruysscher, Joost J.C. Verhoeff, C. Hurkmans, Frank J. Lagerwaard, P.P. van der Toorn, A. Bruynzeel, L. van Veelen, Dianne Hartgerink, Daniëlle B.P. Eekers, E. Dieleman, A. Swaak, S.B. Oei, H. Blommenstein, J. Zindler, A. Swinnen
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 108:e736-e737
Autor:
Dirk De Ruysscher, E. Dieleman, C Hurkmans, Joost J.C. Verhoeff, P.P. van der Toorn, Lieneke van Veelen, G. Wester, A van der Geest, A. Swaak, Dianne Hartgerink, Ruud Wiggenraad, Anna M.E. Bruynzeel, A. Jonkman, J. Zindler, A. Swinnen
BACKGROUND: Stereotactic radiosurgery is a promising treatment option for patients with multiple brain metastases (BM). A multicenter randomized phase III trial (NCT02353000) is ongoing in patients with 4 up to 10 BM to determine the palliative value
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c9dbe33136d3554587adcdd871da7543
https://europepmc.org/articles/PMC6144076/
https://europepmc.org/articles/PMC6144076/
Autor:
Dirk De Ruysscher, M. Zamburlini, Dianne Hartgerink, Richard A. Popple, N. Andratschke, J. Zindler, A. Swinnen, M. Guckenberger
Publikováno v:
Neuro-Oncology. 20:iii309-iii309
BACKGROUND: Stereotactic radiosurgery (SRS) is a promising treatment option for patients with multiple brain metastases (BM). Optimal SRS plan quality is important to minimize the risk of severe side effects such as radionecrosis.(1,2) We studied if